Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHODH | Q02127 | 9/20 | 0.52 |
| ▸ | PTGFR | P43088 | 9/20 | 0.46 |
| ▸ | MMP1 | P03956 | 1/20 | 0.42 |
| ▸ | MMP9 | P14780 | 1/20 | 0.42 |
| ▸ | MMP13 | P45452 | 1/20 | 0.42 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2373180 | 0.90 | DHODH (0.54) | DHODHPTGFRKDM4EMEN1KMT2A | |
| SCHEMBL2372133 | 0.90 | DHODH (0.54) | DHODHPTGFRKDM4EMEN1KMT2A | |
| SCHEMBL2464452 | 0.87 | DHODH (0.52) | DHODHPTGFRKDM4EMEN1KMT2A | |
| SCHEMBL2372070 | 0.86 | DHODH (0.65) | DHODHPTGFRKDM4EMEN1KMT2A | |
| SCHEMBL2371993 | 0.85 | DHODH (0.59) | DHODHPTGFRKDM4EMEN1KMT2A | |
| SCHEMBL14553163 | 0.85 | DHODH (0.59) | DHODHPTGFRKDM4EMEN1KMT2A | |
| SCHEMBL2461722 | 0.84 | DHODH (0.73) | DHODHPTGFR | |
| SCHEMBL2372745 | 0.84 | PTGFR (0.61) | DHODHPTGFRKDM4EMEN1KMT2A | |
| SCHEMBL2373435 | 0.83 | DHODH (0.57) | DHODHPTGFRKDM4EMAPT | |
| SCHEMBL2373029 | 0.83 | DHODH (0.57) | DHODHPTGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011119693-A1 | TRPV4 ANTAGONISTS | GLAXOSMITHKLINE LLC (US) | 2011-09-29 | — | — | WO | disclosed |